ProfileGDS4718 / 203003_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 73% 73% 67% 73% 68% 59% 63% 70% 75% 71% 74% 64% 66% 61% 60% 74% 65% 66% 58% 71% 71% 69% 74% 73% 73% 65% 70% 65% 75% 58% 66% 55% 74% 82% 63% 61% 67% 65% 70% 65% 70% 65% 60% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1097973
GSM549102patient 115, normal, homogenized [OPG study]7.1199473
GSM549104patient 119, normal, homogenized [OPG study]6.6620767
GSM549108patient 138, normal, homogenized [OPG study]7.0858473
GSM549119patient 077, normal, homogenized [OPG study]6.6513968
GSM549133patient 032, cancer, homogenized [OPG study]6.0482859
GSM549139patient 042, cancer, homogenized [OPG study]6.3605163
GSM549099patient 107, normal, homogenized [OPG study]6.8228970
GSM549109patient 139, normal, homogenized [OPG study]7.3139975
GSM549110patient 046, normal, homogenized [OPG study]6.9391871
GSM549114patient 063, normal, homogenized [OPG study]7.2014174
GSM549122patient 082, normal, homogenized [OPG study]6.418864
GSM549134patient 033, cancer, homogenized [OPG study]6.5138166
GSM549136patient 036, cancer, homogenized [OPG study]6.1907261
GSM549140patient 044, cancer, homogenized [OPG study]6.107360
GSM549111patient 047, normal, homogenized [OPG study]7.2927374
GSM549113patient 057, normal, homogenized [OPG study]6.4835865
GSM549132patient 031, cancer, homogenized [OPG study]6.5714466
GSM549137patient 038, cancer, homogenized [OPG study]5.9989558
GSM549142patient 047, cancer, homogenized [OPG study]6.9478871
GSM549100patient 110, normal, homogenized [OPG study]6.8682971
GSM549107patient 135, normal, homogenized [OPG study]6.7767369
GSM549115patient 068, normal, homogenized [OPG study]7.2569174
GSM549116patient 072, normal, homogenized [OPG study]7.1312173
GSM549120patient 078, normal, homogenized [OPG study]7.1695373
GSM549131patient 030, cancer, homogenized [OPG study]6.4489965
GSM549118patient 074, normal, homogenized [OPG study]6.8656270
GSM549129patient 027, cancer, homogenized [OPG study]6.5544865
GSM549123patient 088, normal, homogenized [OPG study]7.3492875
GSM549124patient 006, cancer, homogenized [OPG study]6.019558
GSM549126patient 015, cancer, homogenized [OPG study]6.5456466
GSM549128patient 025, cancer, homogenized [OPG study]5.8110355
GSM549103patient 117, normal, homogenized [OPG study]7.1754474
GSM549117patient 073, normal, homogenized [OPG study]8.0888382
GSM549138patient 041, cancer, homogenized [OPG study]6.3372363
GSM549141patient 045, cancer, homogenized [OPG study]6.1961361
GSM549130patient 028, cancer, homogenized [OPG study]6.5921867
GSM549101patient 111, normal, homogenized [OPG study]6.5309565
GSM549105patient 128, normal, homogenized [OPG study]6.8549870
GSM549106patient 134, normal, homogenized [OPG study]6.5130465
GSM549112patient 048, normal, homogenized [OPG study]6.8211870
GSM549125patient 011, cancer, homogenized [OPG study]6.4963365
GSM549127patient 024, cancer, homogenized [OPG study]6.1892960
GSM549135patient 035, cancer, homogenized [OPG study]6.4753665